Nursing care
Propofol: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Propofol is a milky, lipid-based IV anaesthetic and sedative that acts within seconds and wears off within minutes once stopped. Because it is suspended in a fat emulsion that supports bacterial growth, tubing and the vial are changed every 12 hours, and prolonged high-dose infusions are monitored with triglyceride checks for propofol infusion syndrome.
Mechanism, simply
Propofol enhances GABA activity in the central nervous system, producing rapid, dose-dependent sedation, unconsciousness, and amnesia. Its onset is within about thirty seconds of IV administration, and recovery is similarly fast once the infusion stops, which is why it is prized for procedures where quick wake-up matters.
What makes it physically distinct from most IV drugs is the vehicle it is suspended in: a lipid emulsion, which gives the milky white appearance you will recognise instantly at the bedside. That emulsion is also why it behaves differently from a typical infusion in terms of infection risk, caloric load, and the specific toxicity syndrome unique to this drug.
Indications you will see on the ward
In the ICU, propofol is used for continuous sedation of mechanically ventilated patients, valued for allowing frequent, accurate neuro assessments because sedation lifts quickly once the infusion is paused or stopped. In the OR and procedure suite, it is used for induction and maintenance of general anaesthesia and for procedural sedation during endoscopy, cardioversion, and similar short procedures.
Because recovery is fast and predictable, it is also a common choice for day-case procedures where the patient needs to be alert enough for discharge within hours. Its use requires personnel trained in airway management and continuous cardiorespiratory monitoring, regardless of the setting, because it does depress respiratory drive and blood pressure at sedative and anaesthetic doses.
Assessment before administration
Confirm baseline respiratory status, oxygen saturation, and haemodynamic stability before starting, since propofol can cause dose-dependent hypotension and respiratory depression, sometimes apnoea, especially during induction or with rapid bolus dosing. Ensure resuscitation equipment and personnel qualified in airway management are immediately available.
Ask about egg and soy allergies, since older formulations and some manufacturers' products contain egg lecithin and soybean oil in the emulsion, and check current institutional guidance, as this is an area where practice and formulation have shifted. Review baseline triglyceride levels if a prolonged infusion is anticipated, since this becomes the reference point for monitoring propofol infusion syndrome later.
Toxicity and the antidote
There is no reversal agent for propofol; recovery relies on stopping the infusion and supporting the airway and circulation until the drug clears, which it does quickly given its short half-life. This is different from opioid or benzodiazepine sedation, where naloxone or flumazenil exist as rescue options.
The toxicity that matters most with this drug is propofol infusion syndrome, associated with prolonged, high-dose infusions, particularly in critically ill patients. It presents with metabolic acidosis, hyperkalaemia, rhabdomyolysis, hypertriglyceridemia, and cardiac dysfunction that can progress to arrhythmia and cardiovascular collapse. Rising triglycerides on serial monitoring during a long infusion is an early warning sign, which is why triglyceride checks are part of routine monitoring rather than an incidental lab order.
Interactions that matter
Propofol potentiates other CNS depressants, opioids, benzodiazepines, and inhaled anaesthetics among them, so concurrent use increases the risk of profound sedation, hypotension, and respiratory depression, and doses of either agent may need to be reduced. Anticipate this combined effect any time propofol is added to an existing sedation or analgesia regimen.
Because the emulsion itself carries caloric content, roughly 1.1 kcal per mL from the lipid, it must be factored into a patient's daily nutritional intake during prolonged infusions to avoid unintentional overfeeding, particularly in patients also receiving parenteral or enteral nutrition. The emulsion also supports microbial growth if contaminated, so strict aseptic technique during preparation and administration is essential, and unused drug from an opened vial or syringe is discarded per facility policy rather than saved.
What the patient must be told
Explain that they will lose consciousness quickly, often within seconds of the injection starting, and that recovery is typically just as fast once the medication is stopped, so they should expect to wake fairly promptly after the procedure or infusion ends. Tell them about the transient stinging or burning at the IV site on injection, which is a common and expected sensation, not a sign of a problem.
For patients going home after a procedure, reinforce that they should not drive, operate machinery, or make significant decisions for the remainder of the day, and that they need a responsible adult to accompany them, because residual sedative effects can linger briefly even after they feel alert. Ask about egg or soy allergies as part of patient teaching and consent discussion, given the emulsion's composition.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why does propofol tubing get changed every 12 hours?
Propofol is suspended in a lipid emulsion, which supports bacterial growth more readily than a standard aqueous IV solution. Tubing, and often the vial or syringe, is changed every 12 hours per manufacturer and facility guidance to reduce infection risk.
What is propofol infusion syndrome?
It is a rare but serious complication of prolonged, high-dose propofol infusion, presenting with metabolic acidosis, hyperkalaemia, rhabdomyolysis, elevated triglycerides, and cardiac dysfunction. It is more common in critically ill patients and children, and serial triglyceride monitoring helps catch it early.
Is there an antidote for propofol overdose?
No specific reversal agent exists. Management is supportive: stop the infusion, support the airway and breathing, and manage blood pressure until the drug clears, which typically happens quickly given its short half-life.
Why is propofol white?
It is formulated as a lipid emulsion rather than an aqueous solution, which gives it its characteristic milky white appearance. This is normal and expected; a discoloured or separated emulsion should not be used.
More on pharmacology
Guides on this